Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Industry News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Industry News
Listed Chinese Pharma Cos Maintains Growth in 2016 4/5/2017
China Grants Approval to Boehringer/Lilly Drug for Diabetes 4/5/2017
Financial-related Company News in Brief 3/31/2017
FibroGen Announces CFDA Approval for Pivotal Phase 2/3 Trial of R... (free) 3/31/2017
Wuxi AppTec to List Its Core Drug R&D Business in China 3/31/2017
China's Fosun Pharma Eyes Expansion in European and US Markets 3/30/2017
Hanmi, Innovent to Co-develop A Novel Immuno-oncology Bispecific ... 3/30/2017
China's Economic Retaliation against South Korea Spreads to Healt... 3/29/2017
India Clears Fosun's Acquisition of Gland Pharma 3/29/2017
Korean Firm Alteogen to License Biosimilar Anticancer to Qilu Pha... 3/29/2017
XiAn Janssen under Major Reorganization 3/28/2017
Tsinghua University, Gates Foundation to Set Up Global Drug Disco... 3/28/2017
PwC: Chinese Pharma M&A to Remain Robust 3/27/2017
TaiGen Sells 9% Stake in HEC JV for $20M (free) 3/27/2017
Sihuan to Acquire Ambest Pharma for CNY 1.1 Bln 3/27/2017
CFDA Approves AZ's NSCLC Drug Tagrisso under Priority Review Path... 3/27/2017
2016 R&D Spending of 30 Listed Chinese Pharma Companies 3/24/2017
ShangPharma Announces Strategic Corporate Restructuring of Shangh... (free) 3/24/2017
David Ricks: China Is Now One of Eli Lilly's Core Markets 3/23/2017
Top In-licensing and Overseas M&A Deals in 2016 3/19/2017
18 Chinese Pharma Companies Launched IPO in February 3/19/2017
Snapshot of MNC Winners of New 2017 NRDL Listing 3/19/2017
Suzhou Ribo Secures CNY 270M in Series B Financing Round (free) 3/17/2017
Novartis to Reduce Prices of Two Originator Drugs in China 3/17/2017
Pfizer Announces CFDA Approval of RA Drug Xeljanz in China 3/17/2017
Snapshot of Chinese Pharma M&A Deals in 2016 3/16/2017
BGI Genomics Reinitiates IPO Application for Listing at Shenzhen'... 3/16/2017
Ally Bridge Backs Privatization Deal of Shandong Luoxin Private (free) 3/15/2017
Credit Suisse: BMI and Drug Price Reform to Reduce Pharma Growth ... 3/15/2017
Nhwa Licenses Long Acting Anti-psychotic Drug from Zysis 3/14/2017
Page:12/14    Total number of articles:393  :[<<][11][12][13][14][First]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links